Event Detail Page

Review study abstracts of research grants funded by the Alzheimer's Association International Research Grant Program.

Luxa Biotechnology LLC posted images on LinkedIn

Researchers used retinal pigment epithelial stem cells derived from adult postmortem eye tissue in a phase 1/2a clinical trial. This is the first treatment to show promise for age-related macular degeneration or AMD.

Retinal pigment epithelium (RPE) cell loss in dry age-related macular degeneration leads to progressive vision decline. Stern and others implanted adult RPE stem cell-derived RPE progeny at a 4-week p...

Farjood et al. has set the stage for characterizing RPE heterogeneity by using single-cell sequencing technology to identify cell surface markers compatible with isolating each subpopulation for furth...

The Alzheimer's Association International Conference is the world's largest forum for the dementia research community. Toronto, Canada, and online.

Abstract Recent years have seen major advances in tau-associated brain disorders through interdisciplinary research spanning molecular biology, neuroimaging, clinical trials, and therapeutic develo...

Jared Lamson and Karen Bertasso-Hughes claimed top honors at the 2025 CDPHP Workforce Team Challenge in Albany, finishing first in the 3.5-mile race.

Jared Lamson and Karen Bertasso-Hughes claimed top honors at the 2025 CDPHP Workforce Team Challenge in Albany, finishing first in the 3.5-mile race.

Abstract INTRODUCTION Post-menopausal women constitute about two-thirds of those with Alzheimer's disease (AD). Menopause increases dementia risk by heightening the likelihood of metabolic disease,...

CurePSP Awareness and Memorial Walk Saturday, March 29

Luxa Biotechnology said Thursday that its stem cell therapy helped improve vision in a handful of people with a common form of an age-related eye condition. In its lowest dose ...

CBER, OTP is hosting a virtual scientific public workshop on February 25, 2025, titled “Cell Therapies and Tissue-based Products: A Public Workshop on Generating Scientific Evidence to Facilitate Development.” The purpose of the workshop is to identify and discuss the current state of the science, development, and regulation for cellular therapies